Canada markets close in 2 hours 29 minutes

Myriad Genetics, Inc. (MYGN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
19.24+1.03 (+5.63%)
As of 01:30PM EDT. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2021-12-31
2020-06-30
2019-06-30
Total Revenue
672,300
690,600
638,600
851,100
Cost of Revenue
191,300
197,600
186,100
201,000
Gross Profit
481,000
493,000
452,500
650,100
Operating Expenses
Research Development
80,800
81,900
77,200
85,900
Selling General and Administrative
555,900
599,800
510,100
555,500
Total Operating Expenses
636,700
681,700
587,300
641,400
Operating Income or Loss
-155,700
-188,700
-134,800
8,700
Interest Expense
3,100
6,600
10,800
12,000
Total Other Income/Expenses Net
110,000
137,500
-80,700
100
Income Before Tax
-48,000
-57,100
-223,300
0
Income Tax Expense
-30,400
-29,900
-23,700
-4,400
Income from Continuing Operations
-17,600
-27,200
-199,600
4,400
Net Income
-17,600
-27,200
-199,500
4,600
Net Income available to common shareholders
-17,600
-27,200
-199,500
4,600
Basic EPS
-
-0.35
-2.69
0.06
Diluted EPS
-
-0.35
-2.69
0.06
Basic Average Shares
-
78,000
74,300
73,500
Diluted Average Shares
-
78,000
74,300
76,000
EBITDA
-
12,300
-140,500
85,000